4//SEC Filing
Abrams Jeffrey J 4
Accession 0001421168-12-000003
CIK 0001360214other
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 7:04 PM ET
Size
8.4 KB
Accession
0001421168-12-000003
Insider Transaction Report
Form 4
Abrams Jeffrey J
Director
Transactions
- Award
Option (Right to Buy)
2012-04-01+300,000→ 311,250 totalExercise: $0.90From: 2012-04-01Exp: 2022-03-31→ Common Stock (300,000 underlying) - Award
Option (Right to Buy)
2012-04-01+125,000→ 436,250 totalExercise: $0.90From: 2012-04-01Exp: 2017-03-31→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]The stock options, granted on April 1, 2012, were granted pursuant to the Issuer's 2007 Stock Incentive and Awards Plan. Mr. Abram's options vest over a 1 year period at a strike price of $0.90, with 25,000 options vesting monthly for the next twelve month period. As of the date of this Form 3 filing, options to purchase 50,000 shares of the Issuer's common stock are exercisable, but no options have been exercised.
- [F2]The stock options, granted on April 1, 2012, were granted pursuant to the Issuer's 2007 Stock Incentive and Awards Plan. Mr. Abram's options maintain a strike price of $0.90, and vest quarterly over a one year term with the initial 31,250 options vesting on June 30, 2012, the next 31,250 options vesting on September 30, 2012, the next 31,250 options vesting on December 31, 2012 and the final 31,250 options vesting on March 31, 2013.
Documents
Issuer
Imprimis Pharmaceuticals, Inc.
CIK 0001360214
Entity typeother
Related Parties
1- filerCIK 0001421168
Filing Metadata
- Form type
- 4
- Filed
- Apr 26, 8:00 PM ET
- Accepted
- Apr 27, 7:04 PM ET
- Size
- 8.4 KB